SEC Form 4 · accession 0001546417-18-000061
Bloomin' Brands, Inc. · BLMN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph John Kadow
Officer — EVP, Chief Legal Officer
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 12:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001546417
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2018 | M | 134,250 | $10.03 | A | 461,131 | D | |
| Common Stock | Mar 2, 2018 | M | 19,810 | $6.50 | A | 480,941 | D | |
| Common StockF1 | Mar 2, 2018 | S | 280,941 | $23.22 | D | 200,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $10.03 | Mar 2, 2018 | M | 134,250 | D | — | Dec 9, 2021 | Common Stock | 134,250 | 0 | D |
| Stock Option (right to buy)F3 | $6.50 | Mar 2, 2018 | M | 19,810 | D | — | Apr 6, 2020 | Common Stock | 19,810 | 0 | D |
| Restricted Stock UnitsF4,F5,F6 | $0.00 | holding | — | — | — | — | — | Common Stock | 8,899 | 8,899 | D |
| Restricted Stock UnitsF4,F7,F6 | $0.00 | holding | — | — | — | — | — | Common Stock | 9,446 | 9,446 | D |
| Restricted Stock UnitsF4,F8,F6 | $0.00 | holding | — | — | — | — | — | Common Stock | 7,543 | 7,543 | D |
| Stock Option (right to buy)F9 | $24.10 | holding | — | — | — | — | Feb 23, 2028 | Common Stock | 20,840 | 20,840 | D |
| Stock Option (right to buy)F10 | $17.27 | holding | — | — | — | — | Feb 24, 2027 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (right to buy)F11 | $17.15 | holding | — | — | — | — | Feb 25, 2026 | Common Stock | 35,165 | 35,165 | D |
| Stock Option (right to buy)F12 | $25.36 | holding | — | — | — | — | Feb 26, 2025 | Common Stock | 24,510 | 24,510 | D |
| Stock Option (right to buy)F2 | $25.32 | holding | — | — | — | — | Feb 27, 2024 | Common Stock | 24,331 | 24,331 | D |
| Stock Option (right to buy)F2 | $17.40 | holding | — | — | — | — | Feb 26, 2023 | Common Stock | 30,229 | 30,229 | D |
Explanation of responses
- F1Price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $23.00 to $23.665. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.
- F10These stock options, in the original grant amount of 30,000, began vesting in four equal annual installments on February 24, 2018.
- F11These stock options, in the original grant amount of 35,165, began vesting in four equal annual installments on February 25, 2017.
- F12These stock options, in the original grant amount of 24,510, began vesting in four equal annual installments on February 26, 2016.
- F2These stock options are fully vested.
- F3These stock options are replacement stock options and are fully vested.
- F4Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- F5These restricted stock units, in the original grant amount of 8,899, will begin vesting in four equal annual installments on February 23, 2019.
- F6This field is not applicable.
- F7These restricted stock units, in the original grant amount of 12,594, began vesting in four equal annual installments on February 24, 2018.
- F8These restricted stock units, in the original grant amount of 15,085, began vesting in four equal annual installments on February 25, 2017.
- F9These stock options, in the original grant amount of 20,840, will begin vesting in four equal annual installments on February 23, 2019.